New Sleeping Sickness Drug Gets Green Light
Fexinidazole is a new drug for the treatment of Human African Trypanosomiasis commonly known as sleeping sickness. It is the first all-oral treatment for the disease which is transmitted by the bite of a tsetse fly, and has been approved by the European Medicines Agency.
Tsetse fly (file photo).
ANGOP, 7 May 2018
Twenty - one positive cases of sleeping sickness were diagnosed in the last two weeks in the municipality of Banga, Cuanza Norte province, during the prospecting campaign held by… Read more »
Nation, 30 January 2017
Kenya Tsetse and Trypanosomiasis Eradication Council (KENTTEC) has warned of rise in cases of sleeping sickness in the country. Read more »